Search Results

How Remdesivir Became the First and Biggest Hope for Treating COVID-19.

• Authors : Park, Alice

Subjects: REMDESIVIR; COVID-19; COVID-19 treatment

• Source: TIME Magazine. 6/1/2020, Vol. 195 Issue 20/21, p58-65. 8p. 11 Color Photographs.

Record details

Gilead Says FDA Verdict on Outpatient Remdesivir Could Come Soon.

• Authors : Langreth, Robert

Subjects: REMDESIVIR; OUTPATIENTSUNITED States. Food & Drug Administration

• Source: Bloomberg.com. 1/10/2022, p1-2. 2p.

Record details

Gilead Says FDA Verdict on Outpatient Remdesivir Likely Soon.

• Authors : Langreth, Robert

Subjects: REMDESIVIR; OUTPATIENTSUNITED States. Food & Drug Administration

• Source: Bloomberg.com. 1/10/2022, p1-2. 2p.

Record details

Can changing the prodrug moiety in remdesivir be a life-saving strategy in COVID-19 infection?

• Authors : Prabha, Praisy K.¹; Prakash, Ajay²; Medhi, Bikash²

Subjects: *COVID-19; *REMDESIVIR; *MOIETIES (Chemistry)

• Source: Indian Journal of Medical Research. Jan2023, Vol. 157 Issue 1, p100-103. 4p.

Record details

Clinical evolution and mortality of critically ill patients with SARS-CoV-2 pneumonia treated with remdesivir in an adult intensive care unit of Paraguay.

• Authors : Figueredo, Jessica¹ (AUTHOR); Lopez, Lorena Fontclara¹ (AUTHOR); Leguizamon, Belinda Figueredo¹ (AUTHOR)

Subjects: *INTENSIVE care units; *REMDESIVIR; *CRITICALLY illPARAGUAY

• Source: BMC Infectious Diseases. 1/2/2024, Vol. 24 Issue 1, p1-7. 7p.

Record details

Response to Özdemir Ö on "Kounis syndrome due to remdesivir allergy".

• Authors : Beneki, Eirini¹ (AUTHOR); Dimitriadis, Kyriakos¹ (AUTHOR) ; Antonopoulos, Alexandros¹ (AUTHOR)

Subjects: *REMDESIVIR; *ALLERGIES; *CARDIOTOXICITY

• Source: Clinical Toxicology (15563650). Apr2024, Vol. 62 Issue 4, p275-276. 2p.

Record details

Comment on Beneki E, Dimitriadis K, Antonopoulos A, Aggeli K & Tsioufis K. Kounis syndrome due to remdesivir allergy.

• Authors : Özdemir, Öner¹ (AUTHOR)

Subjects: *KOUNIS syndrome; *REMDESIVIR; *HEALTH facilities

• Source: Clinical Toxicology (15563650). Apr2024, Vol. 62 Issue 4, p274-275. 2p.

Record details

Impact of Remdesivir on inflammatory and prognostic markers of COVID-19: Findings of an event-monitoring studys.

• Authors : Singh, Shruti¹ (AUTHOR); Sinha, Nishi¹ (AUTHOR); Lohani, Pallavi² (AUTHOR)

Subjects: *PROGNOSIS; *REMDESIVIR; *DRUG side effects

• Source: Journal of Family Medicine & Primary Care. Dec2023, Vol. 12 Issue 12, p3135-3141. 7p.

Record details

Remdesivir versus Favipiravir in Hospitalized Patients with Moderate to Severe COVID-19 Pneumonia: A Propensity Score-Matched Retrospective Cohort Study

• Authors : Chavalertsakul, Karuna; Sutherasan, Yuda; Petnak, Tananchai

• Source: International Journal of General Medicine. May 31, 2024, Vol. 17, p2163, 13 p.

Record details

Real-world evaluation of early remdesivir in high-risk COVID-19 outpatients during Omicron including BQ.1/BQ.1.1/XBB.1.5.

• Authors : Molina, Kyle C.; Webb, Brandon J.; Kennerley, Victoria

Subjects: SARS-CoV-2 Omicron variant; COVID-19 pandemic; REMDESIVIR

• Source: BMC Infectious Diseases; 8/8/2024, Vol. 24 Issue 1, p1-8, 8p

Record details